心脏停搏液

  • 网络Cardioplegia;cardioplegic solution
心脏停搏液心脏停搏液
  1. 心脏停搏液对未成熟心肌的保护作用

    Experimental Study of Effects of Cardioplegia on Immature Myocardial Protection

  2. 极化型与去极化型心脏停搏液对离体大鼠心肌细胞胞质游离钙离子含量的影响

    Effect of two different cardioplegia on calcium concentration of isolated cardiomyocytes of rat

  3. A组无明显变化,且在T3与B组比较有显著性差异(P<005)。结论冷温血停搏液联合灌注对瓣膜病病人的心肌再灌注损伤的抑制效应优于冷血心脏停搏液。

    Conclusion Warm blood cardioplegic solution is more effective in reducing myocardial reperfusion injury than cold blood cardioplegic solution in patients with valvular heart disease .

  4. 方法心瓣膜直视术患者33例,随机分为常温氧合血心脏停搏液组(WBC组)和冷晶体心脏停搏液组(CCC组)。

    Methods Thirty three patients were randomly divided into warm blood cardioplegia and cold crystalloid cardioplegia group .

  5. Thomas号液不能改变这种变化,而冷血心脏停搏液可使新生豚鼠心肌再灌注后的Gsα和Giα蛋白含量恢复至缺血前水平。

    Thomas ⅱ on these changes is verified , but recovery to the level of Gs α and Gi α before ischemia is achieved by cold blood cardioplegic solution after ischemia and reperfusion .

  6. 目的:研究河豚毒素(tetrodotoxin,TTX)心脏停搏液对离体大鼠缺血/再灌注心肌在器官水平和细胞水平的保护作用,探索新的心肌保护方法。方法:实验Ⅰ。

    Objective : To investigate the protective effects of cardioplegia with sodium channel inhibitor tetrodotoxin ( TTX ) on ischemia / reperfusion models of isolated rat hearts and isolated cardiomyocytes so as to explore a new myocardial protective method .

  7. 康斯特保护液与其它心脏停搏液心肌保护作用比较

    Compare the Myocardial Protection Effect of HTK with Other Cardioplegic Solutions

  8. 钾异心心脏停搏液临床应用初探

    Clinical Application of Cardioplegic Solution Containing Potassium , Verapamil and Propranolol

  9. 极化心脏停搏液对离体大鼠心脏的保护作用

    Protective effects of polarizing cardioplegic solution in isolated rat hearts

  10. 腺苷、谷氨酸心脏停搏液的实验研究

    Experimental study of adenosine and / or glutamate in cardioplegia

  11. 腺苷增强冷血心脏停搏液的心肌保护作用研究

    The Study on the Myocardial Protection of Adenosine Enriched Cold Blood Cardioplegia

  12. 氧合血心脏停搏液保护心肌的研究

    A Comparative Clinical Study of Warm Blood Cardioplegia Versus Cold Crystalloid Cardioplegia for Myocardial Protection

  13. 间歇微温血心脏停搏液改善心肌保护

    Intermittent tepid blood cardioplegia improves clinical outcome

  14. 温血灌注与冷晶体心脏停搏液灌注对心肌酶学的影响

    Influence of Warm Blood Cardioplegic Solution Perfusion and Cold Crystalloid Cardioplegic Solution on Myocardial Enzyme

  15. 目的探讨三甲氧苄嗪增补于心脏停搏液中对离体鼠心再灌注损伤的保护作用。

    Objective To study the protective effects of trimetazidine on rat isolated heart reperfusion injury .

  16. 心脏停搏液预处理对大鼠离体心脏缺血性挛缩及再灌注冠脉流量的影响

    Effects of cardioplegic preconditioning on ischemic contraction and coronary flow in isolated reperfusion in rat hearts

  17. 冠状窦堵塞对心脏停搏液灌注压力的影响

    The Dynamic Study of Antegrade Cardioplegic Infusion Rate and Coronary Sinus Occlusion on the Isolated Rabbit Heart

  18. 目的探讨温血高钾心脏停搏液诱导心脏停跳、术中冷血维持及终末温血灌注即温-冷-温技术在先天性心脏病(先心病)矫治术中的心肌保护作用。

    Objective To investigate the Myocardium Protection of warm induction and reperfusion blood cardioplegia on CHD patients .

  19. 目的比较超极化心脏停搏液和去极化心脏停搏液对猪冠状动脉张力的影响。

    Objective To compare the effect of hyperpolarizing cardioplegia and depolarizing cardioplegia on the porcine coronary artery tone .

  20. 临床上腺苷可用于终止室上性心动过速,心肌缺血的药物预处理,以及作为体外循环心脏停搏液的辅剂等。

    It also can be used as a pretreatment drug of myocardial ischemia and used as an adjunct to cardioplegia .

  21. 本文用高效液相色谱间接光度检测法测定了心脏停搏液中钠、钾、钙、镁的含量。

    To determine the content of sodium , kalium , magnesium and calcium in liquor of cardioplegia by HPLC-IPD method .

  22. 河豚毒素心脏停搏液用于离体大鼠心肌保护的实验研究

    Protective Effects of Cardioplegia with Sodium Channel Inhibitor Tetrodotoxin ( TTX ) on Ischemia / Reperfusion Myocardium of Isolated Rat Hearts

  23. 结果:氧合血心脏停搏液持续灌注方法术后低心排血量综合征、室性心律失常发生例数和起搏器使用率较低;

    Results : The results showed that the postoperative complications could be reduced significantly by the method of continuous oxygenated blood cardioplegia .

  24. 心肌保护采用冠状动脉开口顺行灌注+冠状静脉窦逆行灌注冷晶体心脏停搏液。

    Cardiac arrest was obtained by antegrade administration in the coronary ostia and retrograde administration into the coronary sinus with cold crystalloid cardioplegia .

  25. 目的探讨心脏停搏液灌注压力高低对猪冠状动脉血管平滑肌功能及内皮依赖性舒张反应的影响。

    Objective To investigate the effects of perfusion pressure with a cardioplegic solution on endothelium-dependent relaxation and smooth muscle function of porcine coronary artery .

  26. 结论:氧合血心脏停搏液持续灌注比冷晶体心脏停搏液间断灌注在心肌保护方面具有明显的优越性,是一种较好的心肌保护方法。

    Conclusion : The continuous warm oxygenated blood cardioplegia is a good method for myocardial protection , and is superior to intermittent cold crystalloid cardioplegia .

  27. 目的利用猫体外循环模型对比观察间断冷血、持续冷血及持续温血心脏停搏液灌注对长时间停搏心肌的保护作用。

    Objective using the cat cardiopulmonary bypass , the present study was designed to ascertain whether continuous warm blood cardioplegia can prevent arrested heart from myocardial ischemia .

  28. 结论与传统高钾心脏停搏液比较,吡那地尔超极化心脏停搏液无明显的减轻炎性反应作用,其改善心功能的作用也并不优于传统的高钾心脏停搏液。

    Conclusion Compared with traditional hyperkalemic cardioplegic solution , pinacidil hyperpolarized cardioplegic solution could not alleviate the inflammatory response and could not improve the cardiac function after reperfusion .

  29. 目的比较温氧合血连续灌注与冷晶体心脏停搏液间断灌注心肌酶学变化,探索更有效的心肌保护方法。

    Objective To compare the changes of superoxide dismutase ( SOD ) and lipoperoxide ( LPO ) in warm oxygenated blood cardioplegic continuous perfusion ( gruop A ) and with those of cold crystalloid cardioplegic intermittent perfusion ( group B ) to find the effective method of myocardial preservation .

  30. 实验组患者心脏冷停搏液中加入生脉注射液。

    In the experimental group , the Shengmai injection was added to the reformative Thomas solution .